Director and Endowed Chair, Medicinal Chemistry-Associate Professor Rank

Founded in 1819, the University of Cincinnati ranks among the nation’s best urban public research universities. Home to over 50,000 students, 11,000 faculty and staff and 332,000 alumni, UC combines a Top 35 public research university with a physical setting The New York Times calls “the most ambitious campus design program in the country.”  With the launch of Next Lives Here, the Cincinnati Innovation District, a $100 million JobsOhio investment, nine straight years of record enrollment, global leadership in cooperative education, a dynamic academic health center and entry into the Big 12 Conference, UC’s momentum has never been stronger. UC’s annual budget tops $1.65 billion and its endowment totals $1.8 billion.

The University of Cincinnati’s James L. Winkle College of Pharmacy (COP) and the College of Medicine’s (COM’s) Department of Internal Medicine announce a tenure-track faculty position of associate professor rank for an accomplished mid-career medicinal chemist. The successful applicant for the Winkle Chair in Medicinal Chemistry will serve as the medicinal chemistry director for the emerging Cancer Drug Development Institute (CDDI) at the University of Cincinnati (UC). The CDDI will be under the UC Cancer Center, comprised of investigators in the COM, COP, Cincinnati Children’s Hospital Medical Center, and UC Health (clinical arm of adult cancer medicine). The position’s planned start date is August 15, 2024 so that the medicinal chemistry lab will be operational before the end of the calendar year, independent of the CDDI timetable. Primary and secondary faculty appointments will be in the COP and COM, respectively. A ~2000 sq. ft. medicinal chemistry laboratory space plus additional labs for computational and drug assay work are immediately available to the hire, along with a generous start-up package.